Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 16 results for "unique pharmaceutical laboratories"

Cancer Genetics, Inc. Receives New York State Approval for Foc...

Focus::CLL? is the only CLIA-validated and NYS-approved NGS panel for CLL that offers information for patient risk stratification, disease management, and treatment selection Focus::CLL? addresses a significant market of over 120,000 patients in ... Pharmacy Choice, 7 hours ago

1 images for "unique pharmaceutical laboratories"

Guru Focus, 5 months ago

Morphic Therapeutic Raises $51.5M Series A Co-Led by SR One and Pfizer Venture

WALTHAM, Mass.--( BUSINESS WIRE )-- Morphic Therapeutic , a biotechnology company developing a new generation of oral integrin drugs, announced today that it has completed a $51.5 million Series A financing to advance multiple programs into the ...
 Citybizlist38 minutes ago

AbbVie's HUMIRA® (adalimumab) Receives U.S. Food and Drug Administration Approval to Treat Adults with Non-Infectious Intermediate, Posterior and Panuveitis

/PRNewswire/ --AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved HUMIRA® (adalimumab) for the treatment of non-infectious intermediate, posterior and panuveitis.
 Barchart1 hour ago

Ajay A. Jagtiani Joins Miles & Stockbridge's Tysons Corner Office as Principal

Ajay Jagtiani Brings Experienced Patent Prosecution Team to Support I-270 Businesses The full-service mid-Atlantic law firm of Miles & Stockbridge today announced that respected intellectual property lawyer Ajay A. Jagtiani has joined the firm as ...
 Citybizlist2 hours ago

Bio-Rad Release: New Method To Assess Effectiveness Of Genome-Editing Technologies

Droplet Digital PCRBased Assay Quickly and Cost-Effectively Assesses Genome-Editing Events Hercules, CA — June 28, 2016 — Researchers have developed a cost-effective and rapid method for assessing edits generated by CRISPR-Cas9 and other ...
 BioSpace4 hours ago

Cannabis Science Guidance; Corporate Headquarters Relocated to California as it Negotiates for a Los Angeles, California Laboratory/Medical Treatment Center

CBIS Sets the Stage for High-Growth Amidst DEA Historical National Industry Changes for Critical Ailment Treatments & Historic California Voting in November LOS ANGELES, CA--(Marketwired - Jun 30, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), ...
 Financial Buzz5 hours ago

Mitochonic Acid 5 Binds Mitochondria and Ameliorates Renal Tubular and Cardiac Myocyte Damage

* † , Hiroaki Yamaguchi ‡ , Motoi Kikusato § , Osamu Hashizume ‖ , Satoru Nagatoishi ¶ , Akihiro Matsuo * , Takeya Sato ** , Tai Kudo †† , Tetsuro Matsuhashi ‡‡ , Kazutaka Murayama §§ , Yuki Ohba * , Shun Watanabe * , ...
 Journal American Society of Nephrology6 hours ago

DELIVERY PLATFORM - Encochleated Drug Formulations: Enhancing Efficacy, Minimizing Toxicity

ABSTRACT Drugs for serious fungal and microbial infections currently require intravenous administration at doses that are associated with significant toxicity. Orally administered, encochleated formulations of broad-spectrum fungicidal and ...
 Drug Development & Delivery7 hours ago

How will genomics enter day-to-day medicine?

Home » Health » / no comments IMAGE: Ian D. Krantz, M.D., is the director of the Individualized Medical Genetics Center at The Children's Hospital of Philadelphia. view more Credit: The Children's Hospital of Philadelphia A quiet ...
 HealthMediciNet.com7 hours ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less